Thien Huynh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thien Huynh has a total of 450 co-authors. Here are the top co-authors by number of shared publications:
- Waleed Brinjikji
Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
10 shared publications - Michael R. Levitt
Department of Neurological Surgery, University of Washington, Seattle, Washington, USA
8 shared publications - Rabih G. Tawk
Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida, USA
8 shared publications - Markus Alfred Möhlenbruch
Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany
7 shared publications - Adam Andrew Dmytriw
Nuffield Department of Surgical Sciences, Medical Sciences Division, University of Oxford, Oxford, United Kingdom
6 shared publications - Basel Musmar
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, United States
6 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
Bilateral Versus Unilateral Middle Meningeal Artery Embolization for Unilateral Chronic Subdural Hematoma: A Propensity-Weighted Analysis
BACKGROUND: Middle meningeal artery embolization (MMAE) is effective for chronic subdural hematoma, but the optimal strategy for unilateral cases is unclear. We compared bilateral versus unilateral MMAE for unilateral chronic subdural hematoma. METHODS: We retrospectively analyzed 526 patients with unilateral chronic subdural hematoma treated with bilateral (n=95) or unilateral (n=431) MMAE. The primary end points were radiographic: the baseline-normalized percentage reduction in SDH thickness and the proportions achieving ≥50% and ≥80% hematoma resolution on follow-up imaging, compared using inverse probability of treatment weighting with 12 covariates including concomitant surgical evacuation. Functional outcomes (modified Rankin Scale score) and safety were secondary. Robustness of the primary findings to center was assessed by leave-one-center-out analysis. RESULTS: After 12-covariate inverse probability of treatment weighting adjustment, bilateral MMAE was associated with more complete radiographic resolution: more patients achieved 50% or greater hematoma reduction (85.9% versus 67.7%; adjusted odds ratio, 2.90 [95% CI, 1.55–5.41]; P P P =0.02) and faster early resolution on a mixed model ( P =0.02). These radiographic findings were not attributable to any single center on leave-one-center-out analysis. Secondary functional outcomes did not differ: good functional outcome (modified Rankin Scale 0–2), 79.8% versus 76.1% (adjusted odds ratio, 1.24 [95% CI, 0.69–2.21]; P =0.46); ordinal modified Rankin Scale shift, common odds ratio, 1.24 (95% CI, 0.80–1.93; P =0.34). CONCLUSIONS: In this inverse probability of treatment weighting–adjusted analysis, bilateral MMAE was associated with more complete and earlier radiographic hematoma resolution than unilateral MMAE, with a similar safety profile; secondary functional outcomes did not differ. These hypothesis-generating findings from an observational cohort require prospective confirmation.
- 19 November 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
Open AccessBilateral Versus Unilateral Middle Meningeal Artery Embolization for Unilateral Chronic Subdural Hematoma: A Propensity-Weighted Analysis
BACKGROUND: Middle meningeal artery embolization (MMAE) is effective for chronic subdural hematoma, but the optimal strategy for unilateral cases is unclear. We compared bilateral versus unilateral MMAE for unilateral chronic subdural hematoma. METHODS: We retrospectively analyzed 526 patients with unilateral chronic subdural hematoma treated with bilateral (n=95) or unilateral (n=431) MMAE. The primary end points were radiographic: the baseline-normalized percentage reduction in SDH thickness and the proportions achieving ≥50% and ≥80% hematoma resolution on follow-up imaging, compared using inverse probability of treatment weighting with 12 covariates including concomitant surgical evacuation. Functional outcomes (modified Rankin Scale score) and safety were secondary. Robustness of the primary findings to center was assessed by leave-one-center-out analysis. RESULTS: After 12-covariate inverse probability of treatment weighting adjustment, bilateral MMAE was associated with more complete radiographic resolution: more patients achieved 50% or greater hematoma reduction (85.9% versus 67.7%; adjusted odds ratio, 2.90 [95% CI, 1.55–5.41]; P P P =0.02) and faster early resolution on a mixed model ( P =0.02). These radiographic findings were not attributable to any single center on leave-one-center-out analysis. Secondary functional outcomes did not differ: good functional outcome (modified Rankin Scale 0–2), 79.8% versus 76.1% (adjusted odds ratio, 1.24 [95% CI, 0.69–2.21]; P =0.46); ordinal modified Rankin Scale shift, common odds ratio, 1.24 (95% CI, 0.80–1.93; P =0.34). CONCLUSIONS: In this inverse probability of treatment weighting–adjusted analysis, bilateral MMAE was associated with more complete and earlier radiographic hematoma resolution than unilateral MMAE, with a similar safety profile; secondary functional outcomes did not differ. These hypothesis-generating findings from an observational cohort require prospective confirmation.
- 2 November 2026
- Published by Wolters Kluwer Health in Neurosurgery
The Contour Neurovascular System Versus Woven Endobridge for Endovascular Embolization of Cerebral Aneurysms: A Propensity Score-matched Cohort Study
BACKGROUND AND OBJECTIVES: The Woven Endobridge (WEB) and the Contour Neurovascular System (Contour) are both intrasaccular devices used to treat cerebral aneurysms. We compared outcomes of these 2 devices using data from 2 large registries. METHODS: Data were sourced from the WorldWideWEB Consortium, which included 1363 cases treated with WEB from 2017, and a registry of 277 Contour cases from 10 European centers starting the same year. Patient demographics, aneurysm characteristics, procedural specifics, and outcomes were analyzed. Propensity score matching was applied for comparison. RESULTS: Before matching, the Contour group had more men (37.9% vs 30.8%), more asymptomatic cases (83.4% vs 70.3%), and fewer acute subarachnoid hemorrhage cases (10.8% vs 26.2%). After matching, no significant differences were found in demographics or aneurysm characteristics between groups. The median age was 60 years, and median aneurysm dimensions were comparable. Logistic regression showed no significant differences between WEB and Contour in achieving complete occlusion (odds ratio [OR] = 1.01, 95% CI, 0.67-1.52, P = .971), adequate occlusion (OR = 0.85, 95% CI, 0.41-1.76, P = .665), or achieving modified Rankin Scale 0 to 2 at last follow-up (OR = 0.48, 95% CI, 0.21-1.02, P = .064). Retreatment (OR = 2.23, P = .086), thromboembolic complications (OR = 0.75, P = .452), and adjunctive treatment use (OR = 1.93, P = .141) were also similar. CONCLUSION: The WEB and Contour demonstrated comparable clinical and angiographic outcomes in this large multicenter study comprised majority small, asymptomatic cerebral aneurysms.
- 2 November 2026
- Published by Wolters Kluwer Health in Neurosurgery
The Contour Neurovascular System Versus Woven Endobridge for Endovascular Embolization of Cerebral Aneurysms: A Propensity Score-matched Cohort Study
BACKGROUND AND OBJECTIVES: The Woven Endobridge (WEB) and the Contour Neurovascular System (Contour) are both intrasaccular devices used to treat cerebral aneurysms. We compared outcomes of these 2 devices using data from 2 large registries. METHODS: Data were sourced from the WorldWideWEB Consortium, which included 1363 cases treated with WEB from 2017, and a registry of 277 Contour cases from 10 European centers starting the same year. Patient demographics, aneurysm characteristics, procedural specifics, and outcomes were analyzed. Propensity score matching was applied for comparison. RESULTS: Before matching, the Contour group had more men (37.9% vs 30.8%), more asymptomatic cases (83.4% vs 70.3%), and fewer acute subarachnoid hemorrhage cases (10.8% vs 26.2%). After matching, no significant differences were found in demographics or aneurysm characteristics between groups. The median age was 60 years, and median aneurysm dimensions were comparable. Logistic regression showed no significant differences between WEB and Contour in achieving complete occlusion (odds ratio [OR] = 1.01, 95% CI, 0.67-1.52, P = .971), adequate occlusion (OR = 0.85, 95% CI, 0.41-1.76, P = .665), or achieving modified Rankin Scale 0 to 2 at last follow-up (OR = 0.48, 95% CI, 0.21-1.02, P = .064). Retreatment (OR = 2.23, P = .086), thromboembolic complications (OR = 0.75, P = .452), and adjunctive treatment use (OR = 1.93, P = .141) were also similar. CONCLUSION: The WEB and Contour demonstrated comparable clinical and angiographic outcomes in this large multicenter study comprised majority small, asymptomatic cerebral aneurysms.
- 23 October 2026
- Published by Wolters Kluwer Health in Neurosurgery
Machine Learning Prediction of Treatment Failure After Middle Meningeal Artery Embolization for Subdural Hematoma
BACKGROUND AND OBJECTIVES: Middle meningeal artery embolization (MMAE) is effective for chronic subdural hematoma (SDH), but failure rates vary and risk prediction tools are lacking. This study developed and validated a machine learning (ML) model to predict MMAE treatment failure for SDH. METHODS: We conducted an international, multi-institutional retrospective cohort study of patients who underwent MMAE for SDH between 2019 and 2025. The cohort was split into training and test sets, stratified by treatment failure, with all hematomas from each patient assigned to a single cohort to prevent data leakage. Multiple ML algorithms were evaluated using 5-fold cross-validation, with gradient boosting selected as the final model. The primary outcome was treatment failure, defined as rescue surgical evacuation or persistent/recurrent SDH requiring retreatment. Model performance was assessed using area under the curve-receiver operating characteristic. Patients were stratified into low-risk (15%) groups using a priori clinically defined thresholds. RESULTS: Among 692 treated hematomas in the test cohort, 64 (9.2%) experienced treatment failure. The gradient boosting model achieved an area under the curve-receiver operating characteristic of 0.856 (95% CI, 0.803-0.902) before calibration and 0.832 (95% CI, 0.766-0.889) after isotonic calibration, with excellent calibration (Brier score, 0.053). The most important predictors were age-platelet interaction, platelet-hemoglobin ratio, platelet count, SDH thickness, and age. Observed treatment failure was 1.6% (95% CI, 0.4%-5.7%) in the low-risk group (n = 124; 17.9%), 6.0% (95% CI, 4.3%-8.4%) in the medium-risk group (n = 516; 74.6%), and 59.6% (95% CI, 46.1%-71.8%) in the high-risk group (n = 52; 7.5%) ( P < .001 for trend), a 37.2-fold difference between high- and low-risk groups. CONCLUSION: This ML model stratified MMAE patients into risk groups with a 37.2-fold difference in treatment failure. High-risk patients had 59.6% failure, whereas low-risk patients had 1.6% failure. Risk stratification may improve patient selection and monitoring.
- 23 October 2026
- Published by Wolters Kluwer Health in Neurosurgery
Machine Learning Prediction of Treatment Failure After Middle Meningeal Artery Embolization for Subdural Hematoma
BACKGROUND AND OBJECTIVES: Middle meningeal artery embolization (MMAE) is effective for chronic subdural hematoma (SDH), but failure rates vary and risk prediction tools are lacking. This study developed and validated a machine learning (ML) model to predict MMAE treatment failure for SDH. METHODS: We conducted an international, multi-institutional retrospective cohort study of patients who underwent MMAE for SDH between 2019 and 2025. The cohort was split into training and test sets, stratified by treatment failure, with all hematomas from each patient assigned to a single cohort to prevent data leakage. Multiple ML algorithms were evaluated using 5-fold cross-validation, with gradient boosting selected as the final model. The primary outcome was treatment failure, defined as rescue surgical evacuation or persistent/recurrent SDH requiring retreatment. Model performance was assessed using area under the curve-receiver operating characteristic. Patients were stratified into low-risk (15%) groups using a priori clinically defined thresholds. RESULTS: Among 692 treated hematomas in the test cohort, 64 (9.2%) experienced treatment failure. The gradient boosting model achieved an area under the curve-receiver operating characteristic of 0.856 (95% CI, 0.803-0.902) before calibration and 0.832 (95% CI, 0.766-0.889) after isotonic calibration, with excellent calibration (Brier score, 0.053). The most important predictors were age-platelet interaction, platelet-hemoglobin ratio, platelet count, SDH thickness, and age. Observed treatment failure was 1.6% (95% CI, 0.4%-5.7%) in the low-risk group (n = 124; 17.9%), 6.0% (95% CI, 4.3%-8.4%) in the medium-risk group (n = 516; 74.6%), and 59.6% (95% CI, 46.1%-71.8%) in the high-risk group (n = 52; 7.5%) ( P < .001 for trend), a 37.2-fold difference between high- and low-risk groups. CONCLUSION: This ML model stratified MMAE patients into risk groups with a 37.2-fold difference in treatment failure. High-risk patients had 59.6% failure, whereas low-risk patients had 1.6% failure. Risk stratification may improve patient selection and monitoring.
- Open Access
- 15 October 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-14
Liquid Embolic Volume Does Not Predict Outcome After Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Purpose: Middle meningeal artery embolization (MMAE) is increasingly used for chronic subdural hematoma (CSDH), but the relationship between injected liquid-embolic volume and outcomes is unclear. We evaluated dose–outcome associations and searched for a minimum effective dose. Methods: This retrospective multicenter cohort included 313 patients treated with liquid embolic agents at 12 MESH Registry centers from 2016 to 2024. MMAE was performed alone in 172 patients (55.0%) and adjunctively with surgical evacuation in 141 (45.0%). Dose was assessed as total injected volume per patient and normalized to middle meningeal artery diameter, baseline hematoma thickness, and estimated hematoma volume. The primary outcome was a 180-day composite of retreatment, residual or recurrent hematoma > 10 mm, or death. Logistic regression with multiple imputation, restricted cubic splines, and sensitivity analyses evaluated associations and nonlinearity. Results: Median injected volume was 0.60 mL (interquartile range, 0.50–0.90). Center accounted for 44.5% of variation in log volume, whereas hematoma burden accounted for 0.3%. No dose metric was significantly associated with the primary outcome or 90-day recurrence/reoperation. For absolute volume, the odds ratio per interquartile-range increment was 0.80 (95% confidence interval, 0.56–1.16; p = 0.24). No reliable minimum effective dose was identified. Findings remained consistent across sensitivity analyses and treatment indications (interaction p = 0.30). Procedural complications occurred in 6.4% and were not dose-associated. Conclusion: Within the observed range, injected volume alone was not a consistent determinant of outcome and should not be a procedural target after a satisfactory angiographic endpoint. Future studies should evaluate embolic distribution, distal penetration, and vascular territory coverage.
- 15 October 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-14
Open AccessLiquid Embolic Volume Does Not Predict Outcome After Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Purpose: Middle meningeal artery embolization (MMAE) is increasingly used for chronic subdural hematoma (CSDH), but the relationship between injected liquid-embolic volume and outcomes is unclear. We evaluated dose–outcome associations and searched for a minimum effective dose. Methods: This retrospective multicenter cohort included 313 patients treated with liquid embolic agents at 12 MESH Registry centers from 2016 to 2024. MMAE was performed alone in 172 patients (55.0%) and adjunctively with surgical evacuation in 141 (45.0%). Dose was assessed as total injected volume per patient and normalized to middle meningeal artery diameter, baseline hematoma thickness, and estimated hematoma volume. The primary outcome was a 180-day composite of retreatment, residual or recurrent hematoma > 10 mm, or death. Logistic regression with multiple imputation, restricted cubic splines, and sensitivity analyses evaluated associations and nonlinearity. Results: Median injected volume was 0.60 mL (interquartile range, 0.50–0.90). Center accounted for 44.5% of variation in log volume, whereas hematoma burden accounted for 0.3%. No dose metric was significantly associated with the primary outcome or 90-day recurrence/reoperation. For absolute volume, the odds ratio per interquartile-range increment was 0.80 (95% confidence interval, 0.56–1.16; p = 0.24). No reliable minimum effective dose was identified. Findings remained consistent across sensitivity analyses and treatment indications (interaction p = 0.30). Procedural complications occurred in 6.4% and were not dose-associated. Conclusion: Within the observed range, injected volume alone was not a consistent determinant of outcome and should not be a procedural target after a satisfactory angiographic endpoint. Future studies should evaluate embolic distribution, distal penetration, and vascular territory coverage.
- Open Access
- 21 September 2026
- Published by Springer Nature in Neuroradiology
- p. 1-12
Multi-pedicle versus single-pedicle middle meningeal artery embolization for nonacute subdural hematoma
Introduction: Nonacute subdural hematomas (nSDH) are common yet serious extra-axial hemorrhages that result in significant morbidity and mortality. Middle meningeal artery (MMA) embolization (MMAE) is a recent endovascular treatment that involves occlusion of the MMA, inducing hemostasis in and around the hematoma. While many aspects of MMAE have been explored, there is currently limited data on the optimal extent of embolization. Objective: To determine whether single or multiple pedicle embolization of the MMA is superior in inducing hemostasis in nSDH. Methods: We compared single versus multi pedicle embolization by a retrospective multicenter analysis of nSDH patients who underwent MMAE between 2019 and 2024 at participating centers in the MESH (MMA Embolization for Subdural Hematoma) Registry. 679 patients who received a liquid embolic agent with branch-level embolization data were included. Results: While multi-pedicle embolization hastened nSDH thinning at 1 month (5.7 vs. 3.3 mm reduction; difference 2.4 mm, 95% CI 1.0–3.8; P = .002), by 3 months thickness reduction had converged between groups (8.2 vs. 8.4 mm; P = .91). Among 679 patients (456 multi-pedicle, 223 single-pedicle), favorable functional outcome (mRS 0–2) was more frequent with multi-pedicle embolization (53.5% vs. 43.0%; adjusted OR 1.81, 95% CI 1.26–2.60; P = .001), whereas recurrence, rescue surgery, and treatment failure did not differ. Conclusion: Future, multi-center randomized prospective trials are warranted to address confounding variables that limit this observational study. Follow-up beyond 3 months was limited, so durability is unknown.
- 21 September 2026
- Published by Springer Nature in Neuroradiology
- p. 1-12
Open AccessMulti-pedicle versus single-pedicle middle meningeal artery embolization for nonacute subdural hematoma
Introduction: Nonacute subdural hematomas (nSDH) are common yet serious extra-axial hemorrhages that result in significant morbidity and mortality. Middle meningeal artery (MMA) embolization (MMAE) is a recent endovascular treatment that involves occlusion of the MMA, inducing hemostasis in and around the hematoma. While many aspects of MMAE have been explored, there is currently limited data on the optimal extent of embolization. Objective: To determine whether single or multiple pedicle embolization of the MMA is superior in inducing hemostasis in nSDH. Methods: We compared single versus multi pedicle embolization by a retrospective multicenter analysis of nSDH patients who underwent MMAE between 2019 and 2024 at participating centers in the MESH (MMA Embolization for Subdural Hematoma) Registry. 679 patients who received a liquid embolic agent with branch-level embolization data were included. Results: While multi-pedicle embolization hastened nSDH thinning at 1 month (5.7 vs. 3.3 mm reduction; difference 2.4 mm, 95% CI 1.0–3.8; P = .002), by 3 months thickness reduction had converged between groups (8.2 vs. 8.4 mm; P = .91). Among 679 patients (456 multi-pedicle, 223 single-pedicle), favorable functional outcome (mRS 0–2) was more frequent with multi-pedicle embolization (53.5% vs. 43.0%; adjusted OR 1.81, 95% CI 1.26–2.60; P = .001), whereas recurrence, rescue surgery, and treatment failure did not differ. Conclusion: Future, multi-center randomized prospective trials are warranted to address confounding variables that limit this observational study. Follow-up beyond 3 months was limited, so durability is unknown.
- Open Access
- 20 August 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-14
Factors Associated with Short Hospital Stay After Combined Middle Meningeal Artery Embolization and Surgical Evacuation for Chronic Subdural Hematoma
Background: Middle meningeal artery embolization (MMAE) plus surgical evacuation is increasingly used for chronic subdural hematoma (cSDH), but predictors of length of stay (LOS) and outcomes associated with early discharge remain unclear. Methods: We performed a multicenter MESH Registry study (2019–2024) of patients undergoing MMAE and surgical evacuation for symptomatic cSDH. Short-stay discharge was defined as LOS ≤4 days. Predictors were identified using multivariable logistic regression. The 90-day composite adverse event was defined as cSDH recurrence requiring intervention, reintervention (repeat MMAE or surgical evacuation), or 30-day all-cause readmission. Safety was assessed using adjusted logistic regression, generalized estimating equations (GEE), inverse probability of treatment weighting (IPTW), and multiple imputation by chained equations (MICE). Results: Among 647 patients (mean age 72.6 years; 74.0% male), 156 (24.1%) had short-stay discharge. Median LOS was 8 days (IQR 5–15). Older age (aOR 0.76 per 10 years; 95% CI 0.62–0.93; P = 0.008), higher baseline modified Rankin Scale score (aOR 0.79 per point; 95% CI 0.67–0.94; P = 0.007), and greater midline shift (aOR 0.90 per mm; 95% CI 0.85–0.96; P = 0.001) were independently associated with lower odds of short-stay discharge. C‑statistic was 0.683. The 90-day composite event rate was 17.1% in short-stay versus 23.7% in long-stay patients. Short-stay discharge was not significantly associated with the composite outcome on adjusted analysis (aOR 0.56; 95% CI 0.30–1.07; P = 0.08), GEE (aOR 0.61; 95% CI 0.33–1.12; P = 0.11), or MICE (aOR 0.74; 95% CI 0.44–1.25; P = 0.26). IPTW showed a discordant association (OR 0.47; 95% CI 0.24–0.92; P = 0.03). Conclusions: Older age, worse baseline function, and midline shift were associated with longer hospitalization. Short-stay discharge was not associated with a statistically significant increase in adverse-event rates; however, the study was not powered to establish non-inferiority or safety equivalence, and clinically meaningful differences cannot be excluded.
- 20 August 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-14
Open AccessFactors Associated with Short Hospital Stay After Combined Middle Meningeal Artery Embolization and Surgical Evacuation for Chronic Subdural Hematoma
Background: Middle meningeal artery embolization (MMAE) plus surgical evacuation is increasingly used for chronic subdural hematoma (cSDH), but predictors of length of stay (LOS) and outcomes associated with early discharge remain unclear. Methods: We performed a multicenter MESH Registry study (2019–2024) of patients undergoing MMAE and surgical evacuation for symptomatic cSDH. Short-stay discharge was defined as LOS ≤4 days. Predictors were identified using multivariable logistic regression. The 90-day composite adverse event was defined as cSDH recurrence requiring intervention, reintervention (repeat MMAE or surgical evacuation), or 30-day all-cause readmission. Safety was assessed using adjusted logistic regression, generalized estimating equations (GEE), inverse probability of treatment weighting (IPTW), and multiple imputation by chained equations (MICE). Results: Among 647 patients (mean age 72.6 years; 74.0% male), 156 (24.1%) had short-stay discharge. Median LOS was 8 days (IQR 5–15). Older age (aOR 0.76 per 10 years; 95% CI 0.62–0.93; P = 0.008), higher baseline modified Rankin Scale score (aOR 0.79 per point; 95% CI 0.67–0.94; P = 0.007), and greater midline shift (aOR 0.90 per mm; 95% CI 0.85–0.96; P = 0.001) were independently associated with lower odds of short-stay discharge. C‑statistic was 0.683. The 90-day composite event rate was 17.1% in short-stay versus 23.7% in long-stay patients. Short-stay discharge was not significantly associated with the composite outcome on adjusted analysis (aOR 0.56; 95% CI 0.30–1.07; P = 0.08), GEE (aOR 0.61; 95% CI 0.33–1.12; P = 0.11), or MICE (aOR 0.74; 95% CI 0.44–1.25; P = 0.26). IPTW showed a discordant association (OR 0.47; 95% CI 0.24–0.92; P = 0.03). Conclusions: Older age, worse baseline function, and midline shift were associated with longer hospitalization. Short-stay discharge was not associated with a statistically significant increase in adverse-event rates; however, the study was not powered to establish non-inferiority or safety equivalence, and clinically meaningful differences cannot be excluded.
- 12 February 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (3) , 836
Imaging of CSF-Venous Fistulas at the High and Low Ends of the Spine: Techniques and Case Examples
CSF-venous fistulas are a common cause of spontaneous intracranial hypotension. Most CSF-venous fistulas occur in the thoracic spine, and recently described myelographic techniques have been primarily tailored to localize fistulas in this location.1-4 However, a small subset of CSF-venous fistulas can occur at the superior or inferior ends of the spine, ranging from the skull base to the sacrum. In this Video Article, we discuss modifications to decubitus myelography needed to safely and confidently diagnose CSF-venous fistulas at the extremes of the spine, including the skull base and sacrum.5-7 We also show unique case examples of these relatively uncommon leaks, which were found using decubitus digital subtraction or CT myelography with simple technical modifications.
- 12 February 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (3) , 836
Imaging of CSF-Venous Fistulas at the High and Low Ends of the Spine: Techniques and Case Examples
CSF-venous fistulas are a common cause of spontaneous intracranial hypotension. Most CSF-venous fistulas occur in the thoracic spine, and recently described myelographic techniques have been primarily tailored to localize fistulas in this location.1-4 However, a small subset of CSF-venous fistulas can occur at the superior or inferior ends of the spine, ranging from the skull base to the sacrum. In this Video Article, we discuss modifications to decubitus myelography needed to safely and confidently diagnose CSF-venous fistulas at the extremes of the spine, including the skull base and sacrum.5-7 We also show unique case examples of these relatively uncommon leaks, which were found using decubitus digital subtraction or CT myelography with simple technical modifications.
- 9 October 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (12) , 2528-2534
Artificial Intelligence–Driven Detection of Large Vessel Occlusions on NCCT: A Multi-Institutional Study
BACKGROUND AND PURPOSE: Imaging triage of stroke patients is primarily based on perfusion imaging. Simplified triage based on non-contrast CT are limited (NCCT). To evaluate the predictive capability of a deep learning algorithm, “Triage Stroke” (Brainomix 360) in identifying anterior circulation large vessel occlusions (LVO) on NCCT in patients with suspected acute ischemic stroke (AIS). MATERIALS AND METHODS: This multi-institutional study analyzed 612 patients with suspected AIS at 3 US comprehensive stroke centers. A balanced cohort of consecutive patients with and without anterior circulation LVO was analyzed. Ground truth was based on concurrent CTA evaluated by site neuroradiologists. The primary outcome was predictive performance for LVO detection. The secondary outcomes were 1) prospective comparison of NCCT LVO detection against general radiologists and subspecialty neuroradiologists, and 2) the influence of NIHSS on the model. RESULTS: Triage Stroke software detected an LVO on NCCT with a 67% sensitivity and 93% specificity. The positive and negative predictive values were 59% and 95%, respectively, with an area under the curve (AUC) of 0.8. The software’s sensitivity for LVO detection was significantly higher than the group average of all radiologists (difference = 20.5%; CI, 8.26–32.78; P = .001) and was also higher when separated into general and neuroradiology subgroups. The AUC for NCCT LVO was significantly higher than the group of all readers (difference = 11%; CI, 4%–17%; P < .001), and the nonexpert readers (difference = 13%, CI, 7%–20%; P < .001). The addition of NIHSS to the model yielded a high specificity (99%) and similar sensitivity (65%), resulting in the optimum positive predictive value of all models tested (91%). CONCLUSIONS: Triage Stroke software demonstrated strong predictive capabilities for NCCT detection of anterior circulation LVOs outperforming radiologists. Coupled with NIHSS it may simplify identification of endovascular candidates especially in resource-constrained environments worldwide. Graphical Abstract
- 9 October 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (12) , 2528-2534
Artificial Intelligence–Driven Detection of Large Vessel Occlusions on NCCT: A Multi-Institutional Study
BACKGROUND AND PURPOSE: Imaging triage of stroke patients is primarily based on perfusion imaging. Simplified triage based on non-contrast CT are limited (NCCT). To evaluate the predictive capability of a deep learning algorithm, “Triage Stroke” (Brainomix 360) in identifying anterior circulation large vessel occlusions (LVO) on NCCT in patients with suspected acute ischemic stroke (AIS). MATERIALS AND METHODS: This multi-institutional study analyzed 612 patients with suspected AIS at 3 US comprehensive stroke centers. A balanced cohort of consecutive patients with and without anterior circulation LVO was analyzed. Ground truth was based on concurrent CTA evaluated by site neuroradiologists. The primary outcome was predictive performance for LVO detection. The secondary outcomes were 1) prospective comparison of NCCT LVO detection against general radiologists and subspecialty neuroradiologists, and 2) the influence of NIHSS on the model. RESULTS: Triage Stroke software detected an LVO on NCCT with a 67% sensitivity and 93% specificity. The positive and negative predictive values were 59% and 95%, respectively, with an area under the curve (AUC) of 0.8. The software’s sensitivity for LVO detection was significantly higher than the group average of all radiologists (difference = 20.5%; CI, 8.26–32.78; P = .001) and was also higher when separated into general and neuroradiology subgroups. The AUC for NCCT LVO was significantly higher than the group of all readers (difference = 11%; CI, 4%–17%; P < .001), and the nonexpert readers (difference = 13%, CI, 7%–20%; P < .001). The addition of NIHSS to the model yielded a high specificity (99%) and similar sensitivity (65%), resulting in the optimum positive predictive value of all models tested (91%). CONCLUSIONS: Triage Stroke software demonstrated strong predictive capabilities for NCCT detection of anterior circulation LVOs outperforming radiologists. Coupled with NIHSS it may simplify identification of endovascular candidates especially in resource-constrained environments worldwide. Graphical Abstract
- Top Cited Papers
- 10 April 2025
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 392 (14) , 1385-1395
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
Whether the large effect size of endovascular thrombectomy (EVT) for stroke due to large-vessel occlusion applies to stroke due to medium-vessel occlusion is unclear. In a multicenter, prospective, randomized, open-label trial with blinded outcome evaluation, we assigned patients with acute ischemic stroke due to medium-vessel occlusion who presented within 12 hours from the time that they were last known to be well and who had favorable baseline noninvasive brain imaging to receive EVT plus usual care or usual care alone. The primary outcome was the modified Rankin scale score (range, 0 [no symptoms] to 6 [death]) at 90 days, reported as the percentage of patients with a score of 0 or 1. A total of 530 patients from five countries were enrolled between April 2022 and June 2024, with 255 patients assigned to the EVT group and 275 to the usual-care group. Most patients (84.7%) had primary occlusions in a middle-cerebral-artery branch. A modified Rankin scale score of 0 or 1 at 90 days occurred in 106 of 255 patients (41.6%) in the EVT group and in 118 of 274 (43.1%) in the usual-care group (adjusted rate ratio, 0.95; 95% confidence interval [CI], 0.79 to 1.15; P = 0.61). Mortality at 90 days was 13.3% in the EVT group and 8.4% in the usual-care group (adjusted hazard ratio, 1.82; 95% CI, 1.06 to 3.12). Symptomatic intracranial hemorrhage occurred in 14 of 257 patients (5.4%) in the EVT group and in 6 of 272 (2.2%) in the usual-care group. Endovascular treatment for acute ischemic stroke due to medium-vessel occlusion within 12 hours did not lead to better outcomes at 90 days than usual care. (Funded by the Canadian Institutes for Health Research and Medtronic; ESCAPE-MeVO ClinicalTrials.gov number, NCT05151172.).
- 10 April 2025
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 392 (14) , 1385-1395
Top Cited PapersEndovascular Treatment of Stroke Due to Medium-Vessel Occlusion
Whether the large effect size of endovascular thrombectomy (EVT) for stroke due to large-vessel occlusion applies to stroke due to medium-vessel occlusion is unclear. In a multicenter, prospective, randomized, open-label trial with blinded outcome evaluation, we assigned patients with acute ischemic stroke due to medium-vessel occlusion who presented within 12 hours from the time that they were last known to be well and who had favorable baseline noninvasive brain imaging to receive EVT plus usual care or usual care alone. The primary outcome was the modified Rankin scale score (range, 0 [no symptoms] to 6 [death]) at 90 days, reported as the percentage of patients with a score of 0 or 1. A total of 530 patients from five countries were enrolled between April 2022 and June 2024, with 255 patients assigned to the EVT group and 275 to the usual-care group. Most patients (84.7%) had primary occlusions in a middle-cerebral-artery branch. A modified Rankin scale score of 0 or 1 at 90 days occurred in 106 of 255 patients (41.6%) in the EVT group and in 118 of 274 (43.1%) in the usual-care group (adjusted rate ratio, 0.95; 95% confidence interval [CI], 0.79 to 1.15; P = 0.61). Mortality at 90 days was 13.3% in the EVT group and 8.4% in the usual-care group (adjusted hazard ratio, 1.82; 95% CI, 1.06 to 3.12). Symptomatic intracranial hemorrhage occurred in 14 of 257 patients (5.4%) in the EVT group and in 6 of 272 (2.2%) in the usual-care group. Endovascular treatment for acute ischemic stroke due to medium-vessel occlusion within 12 hours did not lead to better outcomes at 90 days than usual care. (Funded by the Canadian Institutes for Health Research and Medtronic; ESCAPE-MeVO ClinicalTrials.gov number, NCT05151172.).
- 30 January 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (2) , 421-425
CSF-Venous Fistulas Arising Intraosseously within Bone Remodeled by Meningeal Diverticula
SUMMARY: CSF-venous fistulas (CVFs) are a common and increasingly recognized type of spinal CSF leak. Most of these fistulas occur in the setting of spontaneous intracranial hypotension, though nonspontaneous cases have been described as well. In most instances, CVFs arise from the dome or neck of nerve root sleeve diverticula (also called meningeal diverticula). Venous drainage typically involves some combination of the internal epidural venous plexus and external vertebral venous plexus. Not uncommonly, venous drainage into the basivertebral venous plexus or other intraosseous veins can be seen. However, the drainage is usually a secondary finding related to normal communication between intraosseous and extraosseous veins. We have recently observed unique cases in which CVFs arise directly within the vertebral elements, resulting in primarily intraosseous drainage. It is possible that this phenomenon is secondary to prominent meningeal diverticula remodeling the adjacent vertebral elements. In this clinical report, we reviewed a multi-institutional series of CVFs exhibiting primary intraosseous drainage, with the goal of illustrating the imaging findings, treatment strategies, and outcomes of the patients. Nine cases were identified demonstrating this phenomenon. We show that intraosseous CVFs can arise in virtually any part of the vertebrae and describe how this feature affects treatment.
- 30 January 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (2) , 421-425
CSF-Venous Fistulas Arising Intraosseously within Bone Remodeled by Meningeal Diverticula
SUMMARY: CSF-venous fistulas (CVFs) are a common and increasingly recognized type of spinal CSF leak. Most of these fistulas occur in the setting of spontaneous intracranial hypotension, though nonspontaneous cases have been described as well. In most instances, CVFs arise from the dome or neck of nerve root sleeve diverticula (also called meningeal diverticula). Venous drainage typically involves some combination of the internal epidural venous plexus and external vertebral venous plexus. Not uncommonly, venous drainage into the basivertebral venous plexus or other intraosseous veins can be seen. However, the drainage is usually a secondary finding related to normal communication between intraosseous and extraosseous veins. We have recently observed unique cases in which CVFs arise directly within the vertebral elements, resulting in primarily intraosseous drainage. It is possible that this phenomenon is secondary to prominent meningeal diverticula remodeling the adjacent vertebral elements. In this clinical report, we reviewed a multi-institutional series of CVFs exhibiting primary intraosseous drainage, with the goal of illustrating the imaging findings, treatment strategies, and outcomes of the patients. Nine cases were identified demonstrating this phenomenon. We show that intraosseous CVFs can arise in virtually any part of the vertebrae and describe how this feature affects treatment.